Long-term evaluation of tailored vs anatomical ablation for persistent atrial fibrillation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The TAILORED-LT study is an extension follow-up of the TAILORED-AF study, focusing on the long-term effectiveness of a tailored ablation strategy that targets spatio-temporal dispersed electrograms combined with pulmonary vein isolation (PVI) compared to the standard anatomical ablation strategy that targets PVI alone. This observational study will follow patients for up to five years to assess their freedom from atrial fibrillation after the initial treatment. Annual follow-ups will be conducted to monitor patient outcomes and any repeat procedures will be at the investigator's discretion. The study utilizes the Volta AF-Xplorer device for the ablation procedures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient who participated in the Tailored AF study
* Patient not withdrawn during the 12-month follow-up period post-index procedure in the Tailored AF study
* Patient able and willing to provide written informed consent to participate in this extension Tailored-LT study

Exclusion Criteria:

* Person deprived of liberty or under guardianship
* Person unable to undergo a medical monitoring for geographical, social or psychological reasons

Where it's running

• Hôpital Saint-Joseph Marseille
  Marseille, France Recruiting
• CHU Lyon, Hôpital Louis Pradel
  Bron, France Not yet recruiting
• Pôle Santé République
  Clermont-Ferrand, France Not yet recruiting
• Hôpital Saint Philibert
  Lomme, France Not yet recruiting
• Hôpital Privé Jacques Cartier
  Massy, France Not yet recruiting
• Hôpital Privé du Confluent
  Nantes, France Not yet recruiting

Study contacts

• Principal investigator: Isabel DEISENHOFER, MD — Deutsches Herzzentrum Muenchen
• Study coordinator: Paola MILPIED
• Email: paola.milpied@volta-medical.com
• Phone: (0)768025499

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

  This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

• Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities

  This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.

  Recruiting University Hospital Augsburg · Augsburg, Bavaria · NCT07857044

• Dual Energy ablation with SmartTouch SF catheter in persistent atrial fibrillation

  This study tests a pulsed field and radiofrequency ablation system to treat persistent atrial fibrillation in adults who have not responded well to prior medications.

  Recruiting at 4 sites Biosense Webster, Inc. · Beijing and 3 other locations · NCT07845682

• Identifying AF patients who may need more than standard ablation using Volta AF-Xplorer II

  This trial tests whether AI-identified dispersion areas during AF ablation can predict recurrence after a standard pulmonary vein isolation in patients with persistent AF.

  Recruiting Volta Medical · Avignon and 4 other locations · NCT07807423

• 4D intracardiac echocardiography to guide left atrial appendage occlusion procedures

  A new 4D ICE catheter is being tested alongside standard imaging to see if it can safely guide left atrial appendage occlusion procedures for adults with atrial fibrillation.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07806890

• Thoracoscopic vs Catheter Ablation as the First Rhythm Control in Atrial Fibrillation with a Large Left Atrium

  This trial tests whether thoracoscopic surgical ablation is better at keeping atrial fibrillation under control than catheter ablation in people with persistent AF and a large left atrium who have not had an ablation before.

  Recruiting Samsung Medical Center · Seoul, Seoul · NCT07783984

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.